Literature DB >> 19562506

Primary cutaneous mucormycosis caused by Rhizomucor variabilis in an immunocompetent patient.

Ying Zhao1, Qiangqiang Zhang, Li Li, Junhao Zhu, Kefei Kang, Lianjun Chen.   

Abstract

Primary cutaneous mucormycosis is an uncommon disease and occurs mainly in patients with immunocompromised disorders. We report a case of cutaneous mucormycosis in an immunocompetent man in whom no definite precipitating factors were noted. The isolate was identified as Rhizomucor variabilis according to the fungus morphology and DNA sequencing results. The lesion was successfully treated with oral Itraconazole, although the in vitro drug-susceptibility test showed resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562506     DOI: 10.1007/s11046-009-9219-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  8 in total

1.  Has antifungal susceptibility testing come of age?

Authors:  John H Rex; Michael A Pfaller
Journal:  Clin Infect Dis       Date:  2002-09-24       Impact factor: 9.079

2.  Molecular determination of dermatophyte fungi using the arbitrarily primed polymerase chain reaction.

Authors:  D Liu; S Coloe; R Baird; J Pedersen
Journal:  Br J Dermatol       Date:  1997-09       Impact factor: 9.302

3.  Primary cutaneous mucormycosis in an immunocompetent host.

Authors:  Wani Tehmeena; Wajahat Hussain; Haroon R Zargar; Abdul Rashid Sheikh; Shabir Iqbal
Journal:  Mycopathologia       Date:  2007-08-04       Impact factor: 2.574

4.  The first case of cutaneous mucormycosis caused by Rhizopus azygosporus.

Authors:  A Fujimoto; K Nagao; K Tanaka; J Yamagami; S-I Udagawa; M Sugiura
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

5.  Primary cutaneous mucormycosis.

Authors:  W L Hicks; K Nowels; J Troxel
Journal:  Am J Otolaryngol       Date:  1995 Jul-Aug       Impact factor: 1.808

Review 6.  Primary cutaneous mucormycosis in an immunocompetent host: report of a case.

Authors:  Arvind Kumar; Gopi C Khilnani; Sandeep Aggarwal; Subodh Kumar; Uma Banerjee; Immaculata Xess
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

7.  Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus.

Authors:  Y Bentur; A Shupak; Y Ramon; A Abramovich; G Wolfin; H Stein; N Krivoi
Journal:  Plast Reconstr Surg       Date:  1998-09       Impact factor: 4.730

Review 8.  Primary cutaneous zygomycosis in a burns patient: a review.

Authors:  James Peter Ledgard; Sebastiaan van Hal; John E Greenwood
Journal:  J Burn Care Res       Date:  2008 Mar-Apr       Impact factor: 1.845

  8 in total
  16 in total

1.  Successful Treatment by Surgery of a Primary Cutaneous Mucormycosis Caused by Mucor irregularis.

Authors:  Guan-Zhao Liang; Wen-Qi Xu; Xiao-Li Zheng; Huan Mei; Gui-Xia Lv; Yong-Nian Shen; Dong-Mei Li; Wei-da Liu
Journal:  Mycopathologia       Date:  2017-10-30       Impact factor: 2.574

2.  Changing Epidemiology of Mucoralean Fungi: Chronic Cutaneous Infection Caused by Mucor irregularis.

Authors:  Jagdish Chander; Mandeep Kaur; Mala Bhalla; Rajpal Singh Punia; Nidhi Singla; Kalyani Bhola; Ana Alastruey-Izquierdo; Alberto M Stchigel; Josep Guarro
Journal:  Mycopathologia       Date:  2015-07-14       Impact factor: 2.574

3.  Drug combinations against Mucor irregularis in vitro.

Authors:  Shuzhen Zhang; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

4.  Disfiguring Mucor irregularis Infection Cured by Amphotericin B and Itraconazole: A Case Report and Treatment Experience.

Authors:  Lin-Wei Wei; Hong Wang; Ying-Gai Song; Jin Yu
Journal:  Mycopathologia       Date:  2019-09-17       Impact factor: 2.574

Review 5.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

6.  Successful treatment of a necrotizing fasciitis patient caused by Mucor indicus with amphotericin B and skin grafting.

Authors:  Yijin Luo; Fanqin Zeng; Xiaowen Huang; Qun Li; Guozhen Tan; Liyan Xi; Changming Lu; Qing Guo
Journal:  Mycopathologia       Date:  2014-02-26       Impact factor: 2.574

Review 7.  Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature.

Authors:  Dong Ming Li; Li De Lun
Journal:  Mycopathologia       Date:  2012-06-29       Impact factor: 2.574

8.  Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia.

Authors:  Mayssa M Abuali; Roberto Posada; Gustavo Del Toro; Elizabeth Roman; Rama Ramani; Sudha Chaturvedi; Vishnu Chaturvedi; Vincent J LaBombardi
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

Review 9.  Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).

Authors:  Anna Skiada; Fanny Lanternier; Andreas H Groll; Livio Pagano; Stephan Zimmerli; Raoul Herbrecht; Olivier Lortholary; George L Petrikkos
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

Review 10.  Mucor irregularis infection around the inner canthus cured by amphotericin B: a case report and review of published literatures.

Authors:  Daoxian Kang; Xian Jiang; Huiying Wan; Yuping Ran; Dan Hao; Chaoliang Zhang
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.